Gayatri Tissue & Papers board to approve un-audited financial results

Virya Resources Ltd. | Engineering - Construction | Construction & Infrastructure | BSE: 512479 | NSE:

06 Feb 2017 Evaluate

Gayatri Tissue & Papers has informed that the meeting of the Board of Directors of the Company will be held on February 14, 2017, to approve the Un-audited financial results for the quarter ended December 31, 2016. In view of the approval of the un audited financial results for the quarter ended December 31, 2016, the trading window for Directors/ KMPs/ Officers/ Designated employees covered under Gayatri Tissue and Papers Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders will be closed from February 09, 2017 to February 16, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Larsen & Toubro	3879.00
Kalpataru Projects	1391.05
NCC	132.85
Rail Vikas Nigam	206.80
KEC International	396.95
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.